United States · FDA National Drug Code directory
Nelarabine
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 70771-1685_d96809f2-f942-4f6d-92b9-0a23ec84226d
- Product NDC
- 70771-1685
- Form
- INJECTION
- Composition / generic term
- Nelarabine
- Labeler
- Zydus Lifesciences Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20211117
- Source listing expiry
- 20261231
Source-listed ingredients
- NELARABINE — 5 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL in 1 CARTON (70771-1685-1) / 50 mL in 1 VIAL · 70771-1685-1
- 6 VIAL in 1 CARTON (70771-1685-8) / 50 mL in 1 VIAL · 70771-1685-8
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →